Loading clinical trials...

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy | Clinical Trials | Clareo Health

COMPLETEDNA

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy

NCT01166659•Transcend Medical, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety and effectiveness of CyPass implantation as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG) who have failed at least one class of topical medical therapy

Eligibility

Age

21 - 99 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnosis of POAG
•Medicated IOP ≥ 21 and ≤ 35 mmHg
•Use of 1 - 4 topical IOP lowering medications

Exclusion Criteria

•Acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma
•Use of oral hypotensive medication treatment for glaucoma
•Previous incisional glaucoma surgery, or any combined cataract-glaucoma procedure
•Clinically significant ocular pathology other than POAG

Key Dates

Start Date

February 1, 2010

Primary Completion Date

May 1, 2013

Completion Date

May 1, 2014

Last Updated

May 15, 2017

Enrollment

ACTUAL participants

Conditions

Primary Open Angle Glaucoma (POAG)

Interventions

CyPass Micro-Stent

DEVICE

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01252849

Primary Open Angle Glaucoma (POAG)

View study

COMPLETEDNA

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

NCT01085357

Primary Open Angle Glaucoma (POAG)Cataract

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy

Inclusion Criteria

Exclusion Criteria

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients